Quantonation portfolio
Qubit Pharmaceuticals logo

Who are they

Founded in 2020 by scientists from leading universities based both in France and in the U.S., Qubit Pharmaceuticals leverages 30 years of research to develop novel drug candidates and therapies for complex targets through high-performance computing and quantum algorithms.

Their technology

No Target Is Undruggable

AI, Quantum Computing and Physics-Based Simulation


Qubit Pharmaceuticals is dedicated to developing breakthrough treatments for life-threatening diseases, with a focus on oncology, inflammation and pandemic response, advancing a diverse drug pipeline with over 40 targets to date. The company's proprietary drug design platform integrates AI, quantum computing and physics-based simulations, delivering state-of-the-art chemical accuracy and 100,000x faster simulations. This combination of speed and accuracy is what makes previously undruggable targets tractable, since accurate simulation at useful scale has long been the limiting factor in computational drug discovery.

Qubit Pharmaceuticals gallery image 1
Qubit Pharmaceuticals gallery image 2
Qubit Pharmaceuticals gallery image 3
Qubit Pharmaceuticals gallery image 4

Our collaboration

We collaborate with Qubit Pharmaceuticals to advance Quantum aided Drug Discovery.

Read more

Subscribe to Quantonation’s newsletter to stay updated on physics and quantum tech